» Articles » PMID: 35269245

Magnetic Nanoparticles in Bone Tissue Engineering

Overview
Date 2022 Mar 10
PMID 35269245
Authors
Affiliations
Soon will be listed here.
Abstract

Large bone defects with limited intrinsic regenerative potential represent a major surgical challenge and are associated with a high socio-economic burden and severe reduction in the quality of life. Tissue engineering approaches offer the possibility to induce new functional bone regeneration, with the biomimetic scaffold serving as a bridge to create a microenvironment that enables a regenerative niche at the site of damage. Magnetic nanoparticles have emerged as a potential tool in bone tissue engineering that leverages the inherent magnetism of magnetic nano particles in cellular microenvironments providing direction in enhancing the osteoinductive, osteoconductive and angiogenic properties in the design of scaffolds. There are conflicting opinions and reports on the role of MNPs on these scaffolds, such as the true role of magnetism, the application of external magnetic fields in combination with MNPs, remote delivery of biomechanical stimuli in-vivo and magnetically controlled cell retention or bioactive agent delivery in promoting osteogenesis and angiogenesis. In this review, we focus on the role of magnetic nanoparticles for bone-tissue-engineering applications in both disease modelling and treatment of injuries and disease. We highlight the materials-design pathway from implementation strategy through the selection of materials and fabrication methods to evaluation. We discuss the advances in this field and unmet needs, current challenges in the development of ideal materials for bone-tissue regeneration and emerging strategies in the field.

Citing Articles

Advances in 3D printing combined with tissue engineering for nerve regeneration and repair.

Liao W, Shi Y, Li Z, Yin X J Nanobiotechnology. 2025; 23(1):5.

PMID: 39754257 PMC: 11697815. DOI: 10.1186/s12951-024-03052-9.


Diacerein-loaded surface modified iron oxide microparticles (SMIOMPs): an emerging magnetic system for management of osteoarthritis via intra-articular injection.

Ali N, Morsi N, Badr-Eldin S, Shamma R Front Bioeng Biotechnol. 2024; 12:1439085.

PMID: 39530062 PMC: 11551035. DOI: 10.3389/fbioe.2024.1439085.


Nanoparticles in Bone Regeneration: A Narrative Review of Current Advances and Future Directions in Tissue Engineering.

Farjaminejad S, Farjaminejad R, Garcia-Godoy F J Funct Biomater. 2024; 15(9).

PMID: 39330217 PMC: 11432802. DOI: 10.3390/jfb15090241.


Enhancing bone regeneration: Unleashing the potential of magnetic nanoparticles in a microtissue model.

Dousti M, Parsa S, Sani F, Bagherzadeh E, Zamanzadeh Z, Dara M J Cell Mol Med. 2024; 28(17):e70040.

PMID: 39219020 PMC: 11366680. DOI: 10.1111/jcmm.70040.


Non-Debye Behavior of the Néel and Brown Relaxation in Interacting Magnetic Nanoparticle Ensembles.

Botez C, Knoop J Materials (Basel). 2024; 17(16).

PMID: 39203139 PMC: 11356192. DOI: 10.3390/ma17163957.


References
1.
Pham B, Colvin E, Pham N, Kim B, Fuller E, Moon E . Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration. Int J Mol Sci. 2018; 19(1). PMC: 5796154. DOI: 10.3390/ijms19010205. View

2.
Dzamukova M, Naumenko E, Lannik N, Fakhrullin R . Surface-modified magnetic human cells for scaffold-free tissue engineering. Biomater Sci. 2020; 1(8):810-813. DOI: 10.1039/c3bm60054h. View

3.
Markides H, McLaren J, Telling N, Alom N, Al-Mutheffer E, Oreffo R . Translation of remote control regenerative technologies for bone repair. NPJ Regen Med. 2018; 3:9. PMC: 5904134. DOI: 10.1038/s41536-018-0048-1. View

4.
Zhao Y, Fan T, Chen J, Su J, Zhi X, Pan P . Magnetic bioinspired micro/nanostructured composite scaffold for bone regeneration. Colloids Surf B Biointerfaces. 2018; 174:70-79. DOI: 10.1016/j.colsurfb.2018.11.003. View

5.
Duan L, Zuo J, Zhang F, Li B, Xu Z, Zhang H . Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway. Int J Nanomedicine. 2020; 15:3605-3620. PMC: 7247730. DOI: 10.2147/IJN.S244453. View